Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03704467
Title Study of Avelumab + M6620 + Carboplatin in Poly (Adenosine Diphosphate Ribose [ADP]-Ribose) Polymerase Inhibitor (PARPi)-Resistant Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | BEL

Facility Status City State Zip Country Details
Marin Cancer Care, Inc. Greenbrae California 94904 United States Details
The Stamford Hospital Stamford Connecticut 06904 United States Details
Covenant Health Care Saginaw Michigan 48604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065-6007 United States Details
Mount Sinai - PRIME New York New York 11041 United States Details
Peggy & Charles Stephenson Oklahoma Cancer Ctr Oklahoma City Oklahoma 73104 United States Details
Mary Crowley Cancer Research Centers Dallas Texas 75251 United States Details
UZ Leuven Leuven Belgium Details
CHU Sart Tilman Liège Belgium Details
GZA Ziekenhuizen - Campus Sint-Augustinus Wilrijk Belgium Details
Royal Cornwall Hospital Truro Cornwall United Kingdom Details
Royal Marsden Hospital Sutton Surrey United Kingdom Details
Royal Marsden Hospital London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field